another thing from the presentation. the scope of the SIOI is continuously increasing
the minimum spend at the moment is for vaccine QA, expanding into new vaccine development. SIOI have two in development
and now assay development and lateral flow tests, which ties in to the 2 papers anteo have on their website, from SIOI and MHRA (UK) from 18 months ago
https://www.anteotech.com/wp-conten...ntification-of-human-serum-IgG-antibodies.pdf
GLTAH
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
-0.001(4.00%) |
Mkt cap ! $32.46M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.3¢ | 1.2¢ | $48.27K | 3.819M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 593080 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 1500000 | 1 |
View Market Depth
| Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
| ADO (ASX) Chart |